Evidence map›Paper›PMID 36542484›Full record

ArticleBrain : a journal of neurology2023

Late-onset sensory-motor axonal neuropathy, a novel SLC12A6-related phenotype.

Sissel Løseth, Helle Høyer, Kim-Mai Le, Eric Delpire, Einar Kinge, Asgeir Lande, Hilde Tveitan Hilmarsen, Toril Fagerheim, Øivind Nilssen, Geir Julius Braathen

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Spectrum of dominant Charcot-Marie-Tooth disease due toJournal of neurology, neurosurgery, and psychiatry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Sissel LøsethDepartment of Neurology and Clinical Neurophysiology, University Hospital of North Norway, 9019 Tromsø, Norway.ORCID 0000-0001-6044-0073
Helle HøyerDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Kim-Mai LeDepartment of Neurology and Clinical Neurophysiology, Medical Division, Akershus University Hospital, 1478 Lørenskog, Norway.
Eric DelpireDepartment of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.ORCID 0000-0002-3702-1599
Einar KingeSandvika Neurocenter, 1337 Sandvika, Norway.
Asgeir LandeDepartment of Medical Genetics, Oslo University Hospital, 0450 Oslo, Norway.
Hilde Tveitan HilmarsenDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Toril FagerheimDepartment of Medical Genetics, Division of Child and Adolescent Health, University Hospital of North-Norway, 9019 Tromsø, Norway.
Øivind NilssenDepartment of Clinical Medicine, The Arctic University of Norway, 9019 Tromsø, Norway.
Geir Julius BraathenDepartment of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway.
Telemark Hospital · NOUniversity Hospital of North Norway · NOAkershus University Hospital · NOOslo University Hospital · NOSandvik (Norway) · NOVanderbilt University · US

Funding

WNK-SPAK signaling in the Distal NephronR01DK093501 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, Paul A Welling · 2012 to 2026
$12.1M
NIDDK NIH HHS R01 DK093501NIH HHS R01 DK93501
6 · The paper itself

Abstract

We describe five families from different regions in Norway with a late-onset autosomal-dominant hereditary polyneuropathy sharing a heterozygous variant in the SLC12A6 gene. Mutations in the same gene have previously been described in infants with autosomal-recessive hereditary motor and sensory neuropathy with corpus callosum agenesis and mental retardation (Andermann syndrome), and in a few case reports describing dominantly acting de novo mutations, most of them with onset in childhood. The phenotypes in our families demonstrated heterogeneity. Some of our patients only had subtle to moderate symptoms and some individuals even no complaints. None had CNS manifestations. Clinical and neurophysiological evaluations revealed a predominant sensory axonal polyneuropathy with slight to moderate motor components. In all 10 patients the identical SLC12A6 missense variant, NM_001365088.1 c.1655G>A p.(Gly552Asp), was identified. For functional characterization, the mutant potassium chloride cotransporter 3 was modelled in Xenopus oocytes. This revealed a significant reduction in potassium influx for the p.(Gly552Asp) substitution. Our findings further expand the spectrum of SLC12A6 disease, from biallelic hereditary motor and sensory neuropathy with corpus callosum agenesis and mental retardation and monoallelic early-onset hereditary motor and sensory neuropathy caused by de novo mutations, to late-onset autosomal-dominant axonal neuropathy with predominant sensory deficits.

Indexed as

Hereditary Sensory and Motor NeuropathyIntellectual DisabilitySymportersAgenesis of Corpus CallosumHumansK Cl- CotransportersMutationPhenotypeK Cl- CotransportersSLC12A6 protein, humanSymportersautosomal-dominant inheritancehereditary motor and sensory neuropathypotassium chloride cotransporter 3SLC12A6 gene

Identifiers

PMID36542484
PMCPMC9976957
OpenAlexW4312057914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.